Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Belimumab open-label phase 2 study in primary Sjögren's syndrome
2008-008045-38Phase 2Active
- Sponsor
- Azienda Ospedaliera di Perugia
- Start
- Apr 2009
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of belimumab in primary Sjögren's syndrome, sponsored by Azienda Ospedaliera di Perugia. Primary endpoints: Composite responder rate and Safety and tolerability of belimumab. Started Apr 2009; status: active.
02
Drugs
belimumab
03
Conditions
primary Sjögren's syndrome
Beyond the preview
Go deeper on 2008-008045-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-008045-38.